If placenta previa is left untreated, the most serious risk is severe, life-threatening bleeding for the mother and oxygen deprivation for the baby. About 19% of women with placenta previa experience significant hemorrhagic complications, and nearly half of affected pregnancies end in preterm birth before 37 weeks. Without proper monitoring and timely delivery planning, both maternal and fetal death are real possibilities.
Placenta previa means the placenta partially or completely covers the opening of the cervix. As the cervix begins to thin and open in the third trimester or during labor, the blood vessels connecting the placenta to the uterus can tear apart, triggering heavy bleeding that can escalate quickly.
Why Bleeding Gets Worse Over Time
The hallmark danger of placenta previa is painless vaginal bleeding, typically starting in the late second or third trimester. This bleeding happens because the lower part of the uterus stretches and thins as pregnancy progresses. Since the placenta is attached in this area, the stretching pulls its blood vessels apart. Early episodes may be light, but each subsequent bleed tends to be heavier and less predictable.
During labor, the cervix dilates fully, which means any placenta sitting over or near that opening will be torn away from the uterine wall. Without medical intervention to deliver the baby by cesarean section before or during active labor, this tearing creates massive, uncontrolled hemorrhage. Roughly 20% of women with placenta previa are delivered emergently because of antenatal bleeding that cannot be safely managed with observation alone.
Risks to the Mother
The primary maternal danger is blood loss. Women with placenta previa are nearly four times more likely to need a blood transfusion than women without the condition, with about 13% receiving red blood cell transfusions. When bleeding is severe enough, it can lead to hypovolemic shock, where the body simply doesn’t have enough blood circulating to keep organs functioning.
About 2% of women with placenta previa require a hysterectomy (removal of the uterus) to stop the bleeding, even when there is no deeper placental invasion into the uterine wall. That rate is roughly five times higher than in pregnancies without previa. In settings with limited access to blood transfusions, surgical teams, and intensive care, the maternal mortality rate from placenta previa has been reported at around 1.2%. In well-resourced hospitals, deaths are rare precisely because the condition is diagnosed early and managed aggressively.
The uterus can also lose its ability to contract properly after delivery, a condition called uterine atony. This happened in about 10.5% of placenta previa cases in one large study, compared to 6.4% in other pregnancies. When the uterus can’t contract, it can’t clamp down on open blood vessels, making postpartum hemorrhage worse.
Risks to the Baby
The consequences for the baby are driven primarily by two things: preterm birth and oxygen deprivation. A meta-analysis of placenta previa outcomes found that 46% of babies were born before 37 weeks, 17% before 34 weeks, and 10% before 32 weeks. Babies born this early face respiratory distress syndrome, feeding difficulties, infection, and long-term developmental challenges that become more severe the earlier they arrive.
When the mother bleeds heavily, the baby’s oxygen supply drops. The placenta is the baby’s only source of oxygen, and significant blood loss from torn placental vessels means less oxygen-rich blood reaching the fetus. This can cause birth asphyxia, which in severe cases leads to brain injury or stillbirth. Neonatal mortality in placenta previa pregnancies has been reported at 10.7 per 1,000 births, compared to 2.5 per 1,000 in unaffected pregnancies, a risk roughly four times higher.
Placenta previa is also linked to intrauterine growth restriction, where the baby doesn’t grow at a normal rate. This association raises concerns about long-term neurodevelopmental outcomes, since babies who are growth-restricted tend to have poorer cognitive and motor development compared to babies who grew appropriately.
The Added Danger of Vasa Previa
About 62% of vasa previa cases at delivery involve a pregnancy that had a low-lying placenta or placenta previa during the second trimester. Vasa previa means fetal blood vessels run unprotected across or near the cervical opening, without the cushion of the placenta or umbilical cord around them. If these exposed vessels rupture during labor or when the membranes break, the baby can bleed out rapidly. A full-term baby has only about 300 mL of blood, so losing even a small amount can be fatal. Without prenatal diagnosis, vasa previa frequently results in stillbirth or neonatal death.
How Placenta Previa Is Tracked
Placenta previa is diagnosed by ultrasound, and the measurement that matters most is how close the placenta’s edge sits to the internal opening of the cervix. If the leading edge is 20 mm or more away from the cervical opening, vaginal birth is generally considered safe. Between 10 and 20 mm at 36 weeks, vaginal delivery may still be possible depending on the clinical picture. When the placenta covers the opening, cesarean delivery is required.
Transvaginal ultrasound is highly accurate for this diagnosis, with a 99% positive predictive value and a 98% negative predictive value when confirming suspected previa from earlier scans. One important additional finding: women with placenta previa whose cervix measured 31 mm or shorter in the third trimester were 16 times more likely to need an emergency cesarean for massive hemorrhage before 34 weeks. This means cervical length helps predict which patients are at highest risk of a sudden, dangerous bleed.
What “Treatment” Actually Looks Like
There is no way to move the placenta. Treatment for placenta previa is really about timing the delivery to balance two competing goals: keeping the baby inside long enough for the lungs to mature, while getting the baby out before a catastrophic bleed occurs. About 66% of placenta previa cases are managed expectantly, meaning the medical team monitors the mother closely, restricts activity, and waits as long as safely possible before scheduling a cesarean section. This approach significantly reduces the rate of complications from prematurity.
When bleeding episodes occur, hospitalization allows for rapid transfusion and emergency delivery if needed. Medications to accelerate fetal lung development are typically given when preterm delivery looks likely. The goal is to reach 36 to 37 weeks when possible, though many women with placenta previa deliver earlier because of bleeding that can’t wait.
“Left untreated” in practical terms means either not knowing the placenta is covering the cervix or not having access to the monitoring, blood products, and surgical delivery that the condition demands. In both scenarios, the pregnancy is far more likely to end in hemorrhagic crisis, emergency surgery, or the death of mother, baby, or both.